Viking aims to enter the billion-dollar weight loss drug market.

Viking Cruises—officially Viking Holdings—bans children, casinos, and even those frosty umbrella drinks. On the surface, it ...

Viking Holdings has carved out a niche in the luxury cruise world by leaning into one word: no. No kids, no casinos, and you ...

According to Benzinga Pro, Viking Therapeutics's peer group average for short interest as a percentage of float is 14.12%, which means the company has more short interest than most of its peers. Did ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

The Norwegian island of Klosterøy is famous for its medieval monastery, but new research suggests it was important long before that.

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $27.05, moving -1.92% from the previous trading ...

Viking Therapeutics is challenging the supremacy of Eli Lilly and Novo Nordisk with potentially best-in-class data for its drug VK2735. See if VKTX is a Buy now.

Viking released data relating to VK2735 today, which confirmed its effectiveness at reducing liver fat. The data is somewhat inconclusive and the market remains unmoved.

DenmarkFans of Viking history and culture will gather to socialize, do battle and barter at this weekend’s moot (market) on Moesgaard Beach, south of Aarhus. Calling itself the oldest market ...